Innovative Eyewear, Inc. (LUCY | DoD: +54.82% | YTD: -34.51% | SmallCap: 10M)

• Profile: The developer of smart eyewear under the Lucyd¬Æ, Nautica¬Æ, Eddie Bauer ¬Æ and Reebok¬Æ brands
• Financing: Innovative Eyewear, Inc. Announces $4.8 Million of Gross Proceeds Raised from Warrant Transactions (Full Text)

Illumina, Inc. (ILMN | DoD: +0.25% | YTD: -30.89% | MidCap: 12.9B)

• Profile: Provides sequencing- and array-based solutions for genetic and genomic analysis
• Acquisition: Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy (Full Text)

Standard BioTools Inc. (LAB | DoD: -3.67% | YTD: -40.00% | SmallCap: 418M)

• Profile: Develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics
• Acquisition: Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina (Full Text)

Abbott Laboratories (ABT | DoD: +0.44% | YTD: +18.41% | LargeCap: 232.4B)

• Profile: An American multinational medical devices and health care company
• Clinical: New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier (Full Text)

AngioDynamics, Inc. (ANGO | DoD: -2.05% | YTD: +11.58% | SmallCap: 394M)

• Profile: A global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities
• Clinical: AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism (Full Text)

NeuroOne Medical Technologies Corporation (NMTC | DoD: -4.01% | YTD: -19.98% | SmallCap: 30M)

• Profile: A medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording
• Clinical: NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System (Full Text)

Perspective Therapeutics, Inc. (CATX | DoD: +0.29% | YTD: +4.53% | SmallCap: 246M)

• Profile: Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer
• Clinical: Perspective Therapeutics Commences Recruitment for [212Pb]VMT-α-NET in the Third Dose Escalation Cohort of its Ongoing Phase 1/2a Clinical Trial (Full Text)

iRhythm Technologies, Inc. (IRTC | DoD: +0.14% | YTD: +62.95% | MidCap: 4.5B)

• Profile: A leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease
• Clinical: New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease (Full Text)

Inogen, Inc. (INGN | DoD: +0.61% | YTD: -27.75% | SmallCap: 171M)

• Profile: A medical technology company offering innovative respiratory products for use in the homecare setting
• Product: Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy (Full Text)

Quanterix Corporation (QTRX | DoD: -4.08% | YTD: -43.12% | SmallCap: 204M)

• Profile: A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics
• Partnership: Quanterix Expands Reach with IVD and Large Reference Labs (Full Text)

Thermo Fisher Scientific Inc. (TMO | DoD: +1.36% | YTD: -23.72% | LargeCap: 148.8B)

• Profile: Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services
• Product: Thermo Fisher Scientific Awarded $94.5 Million U.S. Government Contract to Supply the Navy with Advanced Radiation Detection Systems (Full Text)

Kestra Medical Technologies, Ltd. (KMTS | DoD: -3.06% | YTD: -31.18% | MidCap: 1.1B)

• Profile: Operates as a wearable medical device and digital healthcare company
• Announcement: Kestra Medical Technologies Announces Inclusion in the Russell 2000® and Russell 3000® Indexes (Full Text)

Perspective Therapeutics, Inc. (CATX | DoD: +0.29% | YTD: +4.53% | SmallCap: 246M)

• Profile: Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer
• Event: Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting (Full Text)

Exagen Inc. (XGN | DoD: -1.77% | YTD: +133.98% | SmallCap: 157M)

• Profile: Designs, develops, and commercializes various testing products under the AVISE brand in the United States
• Leadership Update: Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics (Full Text)

Smith & Nephew plc (SNN | DoD: +0.87% | YTD: +20.10% | MidCap: 12.7B)

• Profile: The global medical technology company
• Leadership Update: Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer (Full Text)